Xabier Arias‐Moreno

This study identifies two FDA-approved drugs, Dutasteride and Solifenacin, as potential inhibitors of PrfA in Listeria monocytogenes through computational screening and simulation.

The paper identifies two novel PrfA inhibitors through virtual screening and molecular dynamics simulations, showing potential to inhibit both wild-type and mutant PrfA structures.